Public safety concerns: Centre reveals why it opted for phased Covid vaccination in SC affidavit
Public safety concerns: Centre reveals why it opted for phased Covid vaccination in SC affidavit
Filed in the Supreme Court, the Centre s affidavit says phased vaccination against Covid-19 is being done as per WHO guidelines.
advertisement
UPDATED: March 15, 2021 17:54 IST
[REPRESENTATIVE IMAGE] File photo of a medic preparing a dose of Covid-19 vaccine in Kolkata (Photo Credits: PTI)
HIGHLIGHTS
Allowing vaccination for all would lead to public safety concerns: Centre in affidavit
The matter was heard by a bench of the Supreme Court headed by CJI SA Bobde
FPJ Edit: Coronavirus is still here, pair vaccines with masks
The recrudescence of the Covid-19 virus in large parts of the country is a worrying development, underlying its intractable behaviour as also the propensity of people to blatantly abandon basic precautions against getting infected. Despite the on-going vaccination programme which has seen over two crore Indians already getting their first jabs, the virus is far from being defeated.
At the minimum it is required of all Indians to wear masks in public and not to congregate in large numbers at social, religious, political events. Unfortunately, it is easier said than done. The images on the day of the Shivratri mocked all concerns about the prevailing pandemic. Be that as it may, the authorities should enforce restrictions whenever these are warranted to stop further spread of the virus. The week-long lockdown imposed in Nagpur last week followed an alarming rise in infections. Such stringent steps are not ruled out in ot
After temporary suspension on the use of Oxford-AstraZeneca Covid vaccine in some European countries over concerns regarding blood clots post inoculation, the health ministry on Saturday confirmed that there are no specific reports on the latest confusion.
A select list of stories to read before you start your day.
India’s indigenous COVID-19 vaccine Covaxin from Hyderabad-based Bharat Biotech has been taken off the clinical trial mode and is now authorised for emergency use on a par with Oxford-AstraZeneca’s Covishield, NITI Aayog’s member (health) V.K. Paul said on Thursday.
Access to COVID-19 vaccines, cooperation on technology, and climate change are at the top of the agenda as Prime Minister Narendra Modi will join U.S. President Joseph Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga for a virtual summit of the Quadrilateral Framework (Quad) on Friday the first time leaders of the Indo-Pacific grouping are meeting.
Story highlights
India has already dispatched 125,000 doses of Covaxin, produced by Hyderabad-based Bharat Biotech, to the Islamic Republic.
Continuing its vaccine diplomacy, India will send to Iran 500,000 doses of Indian Covid vaccine Covaxin, the first tranche of which reached the country on Thursday. India has already dispatched 125,000 doses of Covaxin, produced by Hyderabad-based Bharat Biotech, to the Islamic Republic. A tradition of exchanges continues. Made in India vaccines arrive in Iran, tweeted India s External Affairs Minister Dr S Jaishankar.
This is the first shipment of Indian vaccines to Iran. Next week, the country will receive 375,000 doses of Covaxin from India as part of the second consignment. Covaxin has demonstrated an efficacy rate of 81%.